The primary cells market has been witnessing significant progress and growth in recent years. Primary cells are isolated directly from living tissues and have the ability to replicate their in vivo functionality, making them valuable tools in various research applications, drug discovery and development, regenerative medicine, and personalized medicine.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

Primary Cells Market in terms of revenue was estimated to be worth $1.7 billion in 2023 and is poised to reach $2.8 billion by 2028, growing at a CAGR of 10.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market can be attributed to factors such as the is government investments for cell-based research, rising growth in pharmaceutical & biotechnology industries, increasing cancer research, increasing demand for monoclonal antibodies, increasing demand for personalized medicine, and growing advantages of primary human cells over cell lines.

Drivers of Growth:

·         Increasing Demand for Cell-based Assays

·         Advancements in Biotechnology

·         Rising Focus on Personalized Medicine

Challenges:

·         Sourcing and Ethical Considerations

·         Limited Availability and Variability

·         Short Lifespan and Reproducibility

Future Growth:

The primary cells market is expected to witness continued growth in the future. Here are some factors that will contribute to this growth:

·         Advancements in 3D Cell Culture

·         Growing Applications in Regenerative Medicine

·         Increasing Focus on Rare Diseases

·         Technological Innovations

The primary cells market is experiencing progress driven by factors such as the demand for cell-based assays, advancements in biotechnology, and the focus on personalized medicine. However, challenges related to sourcing, variability, and reproducibility need to be addressed. Future growth is expected through advancements in 3D cell culture, regenerative medicine applications, increased focus on rare diseases, and technological innovations.

Browse Complete Report @ https://www.prnewswire.com/news-releases/primary-cells-market-worth-2-8-billion--marketsandmarkets-301870993.html

North America has traditionally been one of the largest regional markets for primary cells. This can be attributed to several factors:

·         Strong Research Infrastructure

·         Well-Established Biotechnology and Pharmaceutical Industry

·         Supportive Regulatory Environment

·         Collaborations and Partnerships

Key Market Players:

Key players in the primary cells market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Lonza Group (Switzerland), Cell Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US), ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated (US), AllCells (US), American Type Culture Collection (US), Axol Bioscience Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US), BioIVT (US), ScienCell Research Laboratories, Inc. (US), ProMab Biotechnologies, Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix (Switzerland), ReachBio LLC (US), AcceGen (US), AMSBIO (UK), and Kosheeka (India).

Recent Developments:

·         In June 2023, iXCells Biotechnologies entered into an agreement with Tebubio to enhance the distribution of the company's products throughout Europe.

·         In March 2022, Lonza launched human stem cell offerings to provide human cord blood CD34+ hematopoietic stem cells (CB-CD34+ HSCs) in large batch sizes, expanding market need.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32854960

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com